Journal of Dental Panacea

Open Access Open Access  Restricted Access Subscription Access

Biomarkers: The Curious Tool for Diagnosis, Prognosis and Treatment


Affiliations
1 ITS Dental college, Greater Noida, UP, India
 

The complication and severity of disease can be reduced if the diagnosis and treatment can be made at early stage. This has led to search of tools called molecular biomarker, which help in early diagnosis of disease, predict future disease progression, and evaluate the response to therapy thus avoiding complications. Biomarkers are being used in both the field of medicine and dentistry for diagnosis, monitoring of therapy outcomes, and drug discovery. In the field of periodontics salivary and GCF biomarkers are being used for detection of active disease state, for monitoring the response to therapy or for measuring the degree of susceptibility to future disease progression. This review highlights about different characteristics of biomarkers and their role in periodontal disease.

Keywords

GCF, Saliva, Therapy Monitoring.
User
Notifications
Font Size


  • Hulka B S. Overview of biological markers. In: Biological markers in epidemiology (Hulka B S, Griffith J D, Wilcosky T C, eds), New York: Oxford University Press, 1990: 3–15.

  • Naylor S. Biomarkers: current perspectives and future prospects. Expert Rev Mol Diagn2003; 3: 525–529.

  • Pradeep Sahu, Neha Pinkalwar, Ravindra Dhar Dubey, Shweta Paroha, Shilpi Chatterjee and Tanushree Chatterjee: Biomarkers: An Emerging Tool for Diagnosis of a Disease and Drug Development, Asian J. Res. Pharm. Sci. 2011; 1(1): 09-16.

  • Gertrude H. Sergievsky Center and the Taub Institute for Research on Alzheimer‟s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University. New York.10032.

  • U. S. Food and Drug Administration. Innovation or stagnation: challenge and opportunity on the critical path to new medical products. Rockville, MD: U.S. Food and Drug Administration, U.S. Department of Health and Human Services; March 2004. www.fda.

  • Sullivan Pepe M. Phases of biomarker development for early detection of cancer; J. Natl. Cancer Inst2001; 93: 1054–1061.

  • Manoj Kumar and Shiv K Sarin. Biomarkers of diseases in medicine, Current Trends In Sciences 2009; 403-417.

  • Avisek Deyati, ErfanYounesi, Martin Hofmann-Apitius Natalia Novac Challenges and opportunities for oncology biomarker discovery, Drug discovery today 2013; 18 (13-14): 614-624.

  • Richard Mayeux. Biomarkers: Potential Uses and Limitations. NeuroRx. 2004; 1(2): 182–188.

  • Mario Taba, Jr, Janet Kinney, Amy S. Kim, and William V. Giannobile, Diagnostic Biomarkers for Oral and Periodontal Diseases: Dent Clin North Am. 2005 July; 49(3): 551–571

  • Priti Basguada Patil and Basgauda Ramesh Patil. Saliva: A diagnostic biomarker of periodontal diseases, J Indian Soc Periodontol 2011; 15(4): 310–317.

  • C D Dwarakanath, Sheetal Oswal. Relevance of gingival crevice fluid components in assessment of periodontal disease - A critical analysis, Journal of Indian Society of Periodontology 2010; 14 (4): 282-286.

  • Vishakha Grover, Anoop Kapoor, Ranjan Malhotra and Gagandeep Kaur. Clinical Relevance of the Advanced Microbiologic and Biochemical Investigations in Periodontal Diagnosis: A Critical Analysis, Journal of Oral Diseases DiseaVolume, 2014 (2014), Article ID 785615, 11 pages

  • Page R C. Host response tests for diagnosing periodontal disease. J Periodontol 1992; 63: 356-66.

  • Eley B M, Cox S W. Advances in periodontal diagnosis, Commercial diagnostic tests based on GCF proteolytic and hydrolytic enzyme levels. Br Dent J 1998; 184: 373-6.

  • Hermann J M, Gonzales J R, Bodeker R H, Vonholdt J, Meyle J. Microassay for the detection of elastase activity in the gingival crevice. J Clin Periodontol 2001; 28: 31-7.

  • K. Shimada, T. Mizuno, K. Ohshio, M. Kamaga, S. Murai, and K. Ito, “Analysis of aspartate aminotransferase in gingival crevicular fluid assessed by using PocketWatch: a longitudinal study with initial therapy,” Journal of Clinical Periodontology2000; 27 (11): 819–823.

  • Mantyla P, Stenman M, Kinane D F, Tikanoja S, Luoto H, Salo T, et al. Gingival crevicular fluid collagenase 2 (MMP-8)test strick for chair side monitoring of periodontitis. J Periodont Res 2003; 38: 436-9

  • UCLA Collaborative Oral Fluids Diagnostic Research Center, 2006, http://hspp.ucla.edu/

  • N. Christodoulides, S. Mohanty, C. S. Miller et al., “Application of microchip assay system for the measurement of C-reactive protein in human saliva, Lab Chip. 2005 Mar; 5(3): 261-9.

  • E. Herr, A. V. Hatch, D. J. Throckmorton et al., “Microfluidic immunoassays as rapid saliva-based clinical diagnostics,” Proceedings of the National Academy of Sciences of the United States of America 2007; 104(13): 5268–5273.

  • Salivary research and diagnostic kits, ” https://www.salimetrics.com/assay-kits.

  • William V. Giannobile, ThomasBeikler, Janet S. kinney, Christoph A, Thiagomorelli & David T. Wong, Saliva as a diagnostic tool for periodontal disease: current state and future directions: Periodontology 2000 2009; 50: 52–64

  • Schipper R, Loof A, de Gischolar_main J, Harthoorn L, Dransfield E, van Heerde W. SELDI-TOF-MS of saliva: Methodology and pre-treatment effects. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 847: 45–53.

  • Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008; 14: 6246–52.

  • . Li Y, St John M A, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004; 10: 8442–50.

  • Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum. 2007; 56: 3588–600.

  • Zia A, Khan S, Bey A, Gupta N D, Mukhtar-Un-Nisar S .Oral biomarkers in the diagnosis and progression of periodontal diseases, Biology and Medicine 2011; 3(2) Special Issue: 45-52.


Abstract Views: 706

PDF Views: 193




  • Biomarkers: The Curious Tool for Diagnosis, Prognosis and Treatment

Abstract Views: 706  |  PDF Views: 193

Authors

Sneh Nidhi
ITS Dental college, Greater Noida, UP, India

Abstract


The complication and severity of disease can be reduced if the diagnosis and treatment can be made at early stage. This has led to search of tools called molecular biomarker, which help in early diagnosis of disease, predict future disease progression, and evaluate the response to therapy thus avoiding complications. Biomarkers are being used in both the field of medicine and dentistry for diagnosis, monitoring of therapy outcomes, and drug discovery. In the field of periodontics salivary and GCF biomarkers are being used for detection of active disease state, for monitoring the response to therapy or for measuring the degree of susceptibility to future disease progression. This review highlights about different characteristics of biomarkers and their role in periodontal disease.

Keywords


GCF, Saliva, Therapy Monitoring.

References





DOI: https://doi.org/10.15636/jdp%2F2015%2Fv1i1%2F80134